GlaxoSmithKline PLC banner

Wall St Price Targets

GSK Price Forecast
Based on 27 analysts

+14% Upside
from $47.76 today

GlaxoSmithKline PLC (GSK)’s 12-month stock price forecast through November 2027 has a consensus target of $54.58, implying 14% upside. The forecast is based on price targets from 27 Wall Street analysts.

GSK Analyst Rating
Based on 9 analysts

avg. 3.33 of 5
Strong buy
2 22%
Buy
1 11%
Hold
5 56%
Sell
0 0%
Strong sell
1 11%

Analysts rate GSK Hold, with 5 of 9 recommending Hold.

GlaxoSmithKline PLC Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GSK's stock price target?
Price Target
54.58 USD

According to Wall Street analysts, the average 1-year price target for GSK is 54.58 USD with a low forecast of 24.84 USD and a high forecast of 84.32 USD.

What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.

What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.

Back to Top